In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire ...

In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space. "There's a ...

GSK has posted a solid set of financial results in the first quarter of this year and said it is not too worried about the financial impact of potential pharma-specific US tariff rules. The UK ...

There haven’t been that many small-cap UK stock success stories over the past few years, but this one is doing… ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

No. 25: Jim Clark's 1965 victory The 1965 Indianapolis ... Bob Pockrass covers NASCAR and IndyCar for FOX Sports. He has spent decades covering motorsports, including over 30 Daytona 500s, with ...

The big event takes place on FOX and motorsports fans are diving into the betting action. There were several crashes during qualifying last weekend. And then on Monday, the league issued penalties ...